Literature DB >> 4898466

The comparative in vitro and in vivo activity of antilymphocyte serum raised by immunization with thymic, splenic, and lymph node lymphocytes.

K Ono, P Bell, N Kashiwagi, T E Starzl.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 4898466      PMCID： PMC2975401     

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  8 in total

1.  Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production.

Authors:  N Kashiwagi; C G Groth; J R Amend; L Gecelter; H Blanchard; T E Starzl
Journal:  Surgery       Date:  1969-03       Impact factor: 3.982

2.  Effect of prior injection of rabbit serum on efficacy of rabbit anti-rat lymphocyte serum.

Authors:  K Ono; C W DeWitt; J H Wallace; E S Lindsey
Journal:  Transplantation       Date:  1969-01       Impact factor: 4.939

3.  Improved technique of heart transplantation in rats.

Authors:  K Ono; E S Lindsey
Journal:  J Thorac Cardiovasc Surg       Date:  1969-02       Impact factor: 5.209

Review 4.  Anti-lymphocytic antibody--a review.

Authors:  K James
Journal:  Clin Exp Immunol       Date:  1967-11       Impact factor: 4.330

5.  The specificity of antilymphocyte sera to thymic, splenic, and leukemic lymphocytes.

Authors:  R Asakuma; A E Reif
Journal:  Cancer Res       Date:  1968-04       Impact factor: 12.701

6.  Antilymphocyte serum as an immunosuppressive agent.

Authors:  P S Russell
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

7.  Allograft survival: effect of antiserums to thymus glands and lymphocytes.

Authors:  H Nagaya; H O Sieker
Journal:  Science       Date:  1965-11-26       Impact factor: 47.728

8.  A trial with heterologous antilymphocyte globulin in man.

Authors:  T E Starzl; L Brettschneider; I Penn; R W Schmidt; P Bell; N Kashiwagi; C M Townsend; C W Putnam
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066
  8 in total
  6 in total

1.  The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients.

Authors:  H Amemiya; T Yokoyama; C W Putnam; M Torisu; T E Starzl
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330

2.  Selected topics on antilymphocyte serum.

Authors:  T E Starzl; I Penn; L Brettschneider; K Ono; N Kashiwagi
Journal:  Fed Proc       Date:  1970 Jan-Feb

3.  Experimental allergic thyroiditis in rats: suppression by heterologous (rabbit) anti-lymphocyte sera to lymph node, thymic and splenic lymphocytes.

Authors:  R N Macsween; K Ono; P R Bell; C M Thomason; T E Starzl
Journal:  Clin Exp Immunol       Date:  1970-02       Impact factor: 4.330

4.  The mechanism behind the effect of ALG on platelets in vivo.

Authors:  A Henricsson; B Husberg; S E Bergentz
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

5.  Heterogeneity of rat peritoneal and alveolar macrophage populations: characterization of their surface antigens by antisera.

Authors:  M A Thomas; R N Macsween
Journal:  Br J Exp Pathol       Date:  1981-02

6.  Activation of human platelets by antibodies to thymocytes and beta 2-microglobulin. I. Qualitative and quantitative aspects of the platelet aggregation induced by HATG and SA beta 2mG.

Authors:  G Csákó; E A Suba; R Wistar
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.